Search results

ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.

ANSTO is one of the world's leading providers of irradiation services for silicon ingots, which are used by the multimillion dollar electronics industry across Europe and Asia. Each year, ANSTO irradiates more than 50 tonnes of silicon.

Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.

The Scientific Computing team supports researchers by performing numerical simulations that complement experimental research. In particular, we use state-of-the-art software to perform computational quantum mechanical modelling, molecular dynamics simulations, lattice dynamics calculation, data analysis and visualisations.

The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.

The first experimental evidence to validate a newly published universal law that provides insights into the complex energy states for liquids has been found using an advanced nuclear technique at ANSTO.

ANSTO showcased its significant contribution to security, safety, and public health during a visit of the Director-General of the International Atomic Energy Agency (IAEA) Rafael Grossi, Minister for Industry and Science Ed Husic, Australian Ambassador to Austria Richard Sinclair and Ambassador for Arms Control and Counter-Proliferation Ian Biggs and other dignitaries at the weekend.

ANSTO User Meeting 2021 - Speakers

ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program

Winners of the Big Ideas Competition 2021

The Biological Small Angle X-ray Scattering beamline will be optimised for measuring small angle scattering of surfactants, nanoparticles, polymers, lipids, proteins and other biological macromolecules in solution. BioSAXS combines combine a state-of-the-art high-flux small angle scattering beamline with specialised in-line protein purification and preparation techniques for high-throughput protein analysis.

Researchers and industry partners from UNSW Australia, the Australian Centre for Nanomedicine, Children’s Cancer Institute and Inventia Life Sciences Pty Ltd have been awarded the 2021 ANSTO Eureka Prize for Innovative Use of Technology for their method to rapidly-produce 3D cell structures

ANSTO's Sydney locations are home to the Open Pool Australian Light-water (OPAL) multi-purpose reactor, the Centre for Accelerator Science (CAS), the Australian Centre for Neutron Scattering, the National Research Cyclotron and the National Deuteration Facility.

The nandin Deep Technology Incubator at ANSTO’s Lucas Heights innovation precinct has welcomed two new members.

The mechanical, electrical, chemical, optical and thermal properties of glass, as determined by its chemical composition and atomic structure, make it a highly useful material with a myriad of applications.

Award recipients Dr Richard Garrett and Dr Nigel Lengkeek with Dr Tien Pham will deliver a Distinguished Lecture on 15 November at ANSTO.